Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Online Tool Designed to Aid Ebola Researchers

By LabMedica International staff writers
Posted on 24 Dec 2014
Biotech researchers and drug developers seeking to find ways to control the Ebolavirus outbreak now have free access to a new online tool that enables visualization of Ebola gene mutations in the context of three-dimensional protein structures.

The Internet site called MuPIT (Mutation Position Imaging Toolkit) Ebola Edition was prepared by biomedical engineers at Johns Hopkins University (Baltimore, MD, USA). More...
This first version of the program, which can be accessed online (please see related links below) provides visualization of user-specified mutations as well as mutations from 101 viral genome sequences, derived from blood samples taken from Ebola patients in West Africa. It includes functional annotations from the [US] National Institutes of Health's Universal Protein Resource database and epitope sequences from the [US] National Institute of Allergy and Infectious Diseases' Immune Epitope and Analysis Resource.

The MuPIT Ebola Edition browser was designed to interact with the new Ebola Genome Browser released recently by the University of California, Santa Cruz (USA). The Ebola Genome Browser offers detailed genetic information about the virus while MuPIT provides three-dimensional views of Ebola’s proteins, making it easier to interpret the functional implications of mutations and their relationship to Ebolavirus evolution and its potential vulnerabilities.

“Learning more about the mutations and binding sites can be enormously valuable in developing new and better ways to treat Ebola patients and, ideally, to keep the virus from infecting people in the first place,” said Dr. Rachel Karchin, associate professor of biomedical engineering at Johns Hopkins University. “Understanding the evolutionary and functional importance of mutations in the Ebola genome is important because it can help us anticipate how the virus will change in the future and then help us to design vaccines capable of neutralizing the virus and protecting against infection.”

Related Links:

Johns Hopkins University
MuPIT Ebola Edition
University of California, Santa Cruz



Gold Member
Blood Gas Analyzer
Stat Profile pHOx
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Sperm Quality Analyis Kit
QwikCheck Beads Precision and Linearity Kit
Hemodynamic System Monitor
OptoMonitor
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.